In studies involving the use of FTO inhibitors, it is reported that use of R-2-hydroxyglutarate (R-2HG) which was previously reported small-molecular inhibitor of FTO shows antileukemic effects in AML cell lines. This evidence concerns the gene FTO and acute myeloid leukemia.